title: Application of high-dose rate (60)Co remote after-loading system for local recurrent neuroblastoma.
abstract: The local control of neuroblastoma is a very important treatment consideration. We describe a patient who received high-dose rate 60Co remote after loading system treatment for local control of recurrent neuroblastoma and discuss the efficacy of high-dose rate 60Co remote after loading system treatment.
authors.affiliation: Department of Pediatric Surgery, Nihon University School of Medicine, Tokyo 173-8610, Japan. sugitou.kiminobu@nihon-u.ac.jp
authors.forename: Kiminobu
authors.initials: K
authors.lastname: Sugito
authors.forename: Takeshi
authors.initials: T
authors.lastname: Furuya
authors.forename: Hide
authors.initials: H
authors.lastname: Kaneda
authors.forename: Takayuki
authors.initials: T
authors.lastname: Masuko
authors.forename: Kensuke
authors.initials: K
authors.lastname: Ohashi
authors.forename: Mikiya
authors.initials: M
authors.lastname: Inoue
authors.forename: Taro
authors.initials: T
authors.lastname: Ikeda
authors.forename: Tsugumichi
authors.initials: T
authors.lastname: Koshinaga
authors.forename: Hiroshi
authors.initials: H
authors.lastname: Yagasaki
authors.forename: Hideo
authors.initials: H
authors.lastname: Mugishima
authors.forename: Toshiya
authors.initials: T
authors.lastname: Maebayashi
mesh_terms: D000008:Abdominal Neoplasms / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use; D001918:Brachytherapy / Q000379:methods*; D002066:Busulfan / Q000008:administration & dosage; D016190:Carboplatin / Q000008:administration & dosage; D002945:Cisplatin / Q000008:administration & dosage; D003037:Cobalt Radioisotopes / Q000627:therapeutic use*; D003131:Combined Modality Therapy; D036101:Cord Blood Stem Cell Transplantation; D003520:Cyclophosphamide / Q000008:administration & dosage; D003561:Cytarabine / Q000008:administration & dosage; D004317:Doxorubicin / Q000008:administration & dosage / Q000031:analogs & derivatives; D005047:Etoposide / Q000008:administration & dosage; D006801:Humans; D007069:Ifosfamide / Q000008:administration & dosage; D007223:Infant; D008297:Male; D008558:Melphalan / Q000008:administration & dosage; D020360:Neoadjuvant Therapy; D009364:Neoplasm Recurrence, Local / Q000532:radiotherapy*; D009447:Neuroblastoma / Q000188:drug therapy / Q000532:radiotherapy* / Q000601:surgery; D036102:Peripheral Blood Stem Cell Transplantation; D011879:Radiotherapy Dosage; D018714:Radiotherapy, Adjuvant; D012074:Remission Induction; D014740:Vidarabine / Q000008:administration & dosage / Q000031:analogs & derivatives; D014750:Vincristine / Q000008:administration & dosage
chemical_list: D003037:Cobalt Radioisotopes; D003561:Cytarabine; D014750:Vincristine; D005047:Etoposide; D004317:Doxorubicin; D003520:Cyclophosphamide; D016190:Carboplatin; C027260:pirarubicin; D014740:Vidarabine; D002066:Busulfan; C024352:fludarabine; D002945:Cisplatin; D008558:Melphalan; D007069:Ifosfamide